Open AccessCT-Guided 125I Brachytherapy in the Treatment of Hepatocellular Carcinoma Refractory to Conventional Transarterial Chemoembolization: A Pilot Study
Author(s) -
Xinyan Xu,
Yiwen Ding,
Tian-Fan Pan,
Feng Gao,
Xiangzhong Huang,
Qiulian Sun
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s305422
Subject(s) - brachytherapy , medicine , refractory (planetary science) , hepatocellular carcinoma , response evaluation criteria in solid tumors , adverse effect , radiology , complete response , nuclear medicine , chemotherapy , radiation therapy , progressive disease , physics , astrobiology
To investigate the efficacy and safety of CT-guided 125 I brachytherapy in the treatment of hepatocellular carcinoma (HCC) refractory to conventional transarterial chemoembolization (TACE).